Bellerophon Therapeutics
BLPH
#10393
Rank
HK$1.13 M
Marketcap
HK$0.09308
Share price
-36.84%
Change (1 day)
-80.19%
Change (1 year)

EPS for Bellerophon Therapeutics (BLPH)

EPS in 2023 (TTM): -HK$9.47

According to Bellerophon Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$9.39. In 2022 the company made an earnings per share (EPS) of -HK$16.13 a decrease over its 2021 EPS that were of -HK$14.58.

EPS history for Bellerophon Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$9.47-41.28%
2022-HK$16.1310.64%
2021-HK$14.58-42.86%
2020-HK$25.5212.67%
2019-HK$22.65-500%
2018HK$5.66-103.53%
2017-HK$160.56-13.75%
2016-HK$186.16-48.13%
2015-HK$358.90882.98%
2014-HK$36.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$39.71-523.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$23.30 148.23%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$23.05-345.64%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$11.87-226.45%๐Ÿ‡บ๐Ÿ‡ธ USA